Evidence map›Paper›PMID 40855275›Full record

ArticleBMC infectious diseases2025

Association between body mass index and the prognosis of community-acquired pneumonia in patients with nontuberculous mycobacterial pulmonary disease: a retrospective cohort study using a nationwide inpatient database.

Goh Tanaka, Shotaro Aso, Taisuke Jo, Hirokazu Urushiyama, Akira Yokoyama, Hiroyuki Tamiya, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Goh TanakaDepartment of Internal Medicine IV, Teikyo University Mizonokuchi Hospital, 5-1-1, Futago, Takatsu-Ku, Kawasaki, Kanagawa, 213-8507, Japan. goh.tanaka@teikyo-u.ac.jp.
Shotaro AsoDepartment of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Taisuke JoDepartment of Respiratory Medicine, The University of Tokyo, Tokyo, Japan.
Hirokazu UrushiyamaDepartment of Respiratory Medicine, The University of Tokyo, Tokyo, Japan.
Akira YokoyamaDepartment of Respiratory Medicine, The University of Tokyo, Tokyo, Japan.
Hiroyuki TamiyaDepartment of Respiratory Medicine, The University of Tokyo, Tokyo, Japan.
Hiroki MatsuiDepartment of Clinical Epidemiology and Health Economics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kiyohide FushimiDepartment of Health Policy and Informatics, Institute of Science Tokyo Graduate School, Tokyo, Japan.
Hideo YasunagaDepartment of Clinical Epidemiology and Health Economics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Funding

The Ministry of Health, Labor and Welfare, Japan 23AA2003The Ministry of Health, Labor and Welfare, Japan 24AA2006
6 · The paper itself

Abstract

backgroundNontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic, debilitating infection that predominantly affects patients with a low body mass index (BMI) and leads to progressive destruction of lung parenchyma. Although pneumonia is a common cause of death among patients with NTM-PD, information on its prognosis is scarce. We evaluated the association between BMI and outcomes in patients with NTM-PD who were hospitalized for community-acquired pneumonia (CAP).

methodsUsing the Japanese Diagnosis Procedure Combination database, we identified patients with NTM-PD hospitalized for CAP between April 1, 2012, and March 31, 2020, prior to the coronavirus disease 2019 epidemic in Japan. We evaluated in-hospital mortality as the primary outcome, and length of hospital stay and readmission due to CAP within 1 year as secondary outcomes. Restricted cubic spline regression models were used to evaluate the impact of BMI as a continuous variable on the study outcomes, adjusting for potential confounders.

resultsWe included 13,302 patients (median age: 79 years [interquartile range {IQR} 72-85]; women: 63.7%; median BMI: 17.6 kg/m

conclusionsThese findings indicate that assessing BMI may play a critical role in stratifying risk and optimizing management of CAP in patients with NTM-PD.

Indexed as

Body Mass IndexCommunity-Acquired InfectionsMycobacterium Infections, NontuberculousPneumoniaAgedAged, 80 and overCommunity-Acquired PneumoniaDatabases, FactualFemaleHospitalizationHospital MortalityHumansInpatientsJapanLength of StayMaleBody mass indexCommunity-acquired pneumoniaIn-hospital mortalityNontuberculous mycobacterial disease

Identifiers

PMID40855275
PMCPMC12379307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.